Elevation of flow temperature of poly(l-lactic acid) gel by controlling its morphology and crystal form
Sign Up to like & getrecommendations! Published in 2017 at "Polymer Bulletin"
DOI: 10.1007/s00289-017-1958-6
Abstract: Complex crystals (ε-crystals) of poly(l-lactic acid) (PLLA) with solvents such as N,N-dimethylformamide (DMF) induce gelation of PLLA by forming fibrous structure. Three procedures to elevate the flow temperature of the PLLA gel were described: formation… read more here.
Keywords: flow temperature; crystal form; plla; gel ... See more keywords
Prepared MnO2 with different crystal forms as electrode materials for supercapacitors: experimental research from hydrothermal crystallization process to electrochemical performances
Sign Up to like & getrecommendations! Published in 2017 at "RSC Advances"
DOI: 10.1039/c7ra06369e
Abstract: The aim of this study was to prepare manganese dioxide with different crystal forms through hydrothermal treatment of MnSO4·H2O–KMnO4 precursors at various precursor ratios, temperatures, time periods, and pH values. The effect of the preparation… read more here.
Keywords: crystallization; different crystal; crystal; crystal form ... See more keywords
A new crystal form of the NSAID dexketoprofen.
Sign Up to like & getrecommendations! Published in 2019 at "Acta crystallographica. Section C, Structural chemistry"
DOI: 10.1107/s2053229619006533
Abstract: Dexketoprofen [(2S)-2-(3-benzoylphenyl)propanoic acid], C16H14O3, is the S-enantiomer of ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, antipyretic and anti-inflammatory properties, and finds applications for the short-term treatment of mild to moderate pain. A new… read more here.
Keywords: dxkp; crystal form; dexketoprofen; new crystal ... See more keywords
Crystal Form of Olmutinib
Sign Up to like & getrecommendations! Published in 2019 at "Journal of The Korean Chemical Society"
DOI: 10.5012/jkcs.2019.63.1.7
Abstract: Olmutinib, N-[3-({2-[4-(4-methylpiperazine-1-yl)aniline]thieno[3,2-d]Pyrimidin-4-yl}oxy)phenyl]prop-2-enamide dihydrochloride monohydrate, Olita is an oral, third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that was developed by Boehringer Ingelheim and Hanmi Pharmaceutical Co. Ltd for the treatment of non-small cell… read more here.
Keywords: form; crystal form; form olmutinib;